646 related articles for article (PubMed ID: 21394009)
1. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic versus open gastrectomy with D2 lymph node dissection for gastric cancer: a meta-analysis.
Wei HB; Wei B; Qi CL; Chen TF; Huang Y; Zheng ZH; Huang JL; Fang JF
Surg Laparosc Endosc Percutan Tech; 2011 Dec; 21(6):383-90. PubMed ID: 22146158
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
4. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
5. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.
Jiang L; Yang KH; Guan QL; Zhao P; Chen Y; Tian JH
J Surg Oncol; 2013 Jun; 107(8):807-14. PubMed ID: 23512524
[TBL] [Abstract][Full Text] [Related]
6. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
7. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
8. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic vs open D2 gastrectomy for locally advanced gastric cancer: a meta-analysis.
Zou ZH; Zhao LY; Mou TY; Hu YF; Yu J; Liu H; Chen H; Wu JM; An SL; Li GX
World J Gastroenterol; 2014 Nov; 20(44):16750-64. PubMed ID: 25469048
[TBL] [Abstract][Full Text] [Related]
10. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
11. D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging.
Schmidt B; Chang KK; Maduekwe UN; Look-Hong N; Rattner DW; Lauwers GY; Mullen JT; Yang HK; Yoon SS
Ann Surg Oncol; 2013 Sep; 20(9):2991-9. PubMed ID: 23760588
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
14. Open vs robot-assisted laparoscopic gastric resection with D2 lymph node dissection for adenocarcinoma: a case-control study.
Caruso S; Patriti A; Marrelli D; Ceccarelli G; Ceribelli C; Roviello F; Casciola L
Int J Med Robot; 2011 Dec; 7(4):452-8. PubMed ID: 21984205
[TBL] [Abstract][Full Text] [Related]
15. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma.
Memon MA; Khan S; Yunus RM; Barr R; Memon B
Surg Endosc; 2008 Aug; 22(8):1781-9. PubMed ID: 18437472
[TBL] [Abstract][Full Text] [Related]
18. A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.
Bostanci EB; Ozer I; Ercan M; Ulas M; Koc U; Karaman K; Dalgic T; Ozogul Y; Akoglu M
Hepatogastroenterology; 2013 May; 60(123):624-7. PubMed ID: 23635437
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
20. Hepatic resection for synchronous hepatic metastasis from gastric cancer.
Qiu JL; Deng MG; Li W; Zou RH; Li BK; Zheng Y; Lao XM; Zhou K; Yuan YF
Eur J Surg Oncol; 2013 Jul; 39(7):694-700. PubMed ID: 23579173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
